Salmaan Keshavjee

12.1k total citations · 3 hit papers
107 papers, 4.7k citations indexed

About

Salmaan Keshavjee is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Salmaan Keshavjee has authored 107 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Infectious Diseases, 60 papers in Epidemiology and 21 papers in Surgery. Recurrent topics in Salmaan Keshavjee's work include Tuberculosis Research and Epidemiology (76 papers), Pneumocystis jirovecii pneumonia detection and treatment (34 papers) and Pneumonia and Respiratory Infections (32 papers). Salmaan Keshavjee is often cited by papers focused on Tuberculosis Research and Epidemiology (76 papers), Pneumocystis jirovecii pneumonia detection and treatment (34 papers) and Pneumonia and Respiratory Infections (32 papers). Salmaan Keshavjee collaborates with scholars based in United States, United Kingdom and Canada. Salmaan Keshavjee's co-authors include Paul E. Farmer, Michael Rich, Kwonjune J. Seung, Sara Stulac, Mercedes C. Becerra, Courtney M. Yuen, Irina Gelmanova, Jennifer Furin, Dennis Falzon and Sergey P. Mishustin and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Salmaan Keshavjee

103 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Structural Violence and Clinical Medicine

2006 642 citations Paul E. Farmer, Salmaan Keshavjee et al. profile →
Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis

2015 485 citations Kwonjune J. Seung, Salmaan Keshavjee et al. Cold Spring Harbor Perspectives in Medicine profile →
The unintended consequences of COVID-19 vaccine policy: why mandates, passports and restrictions may cause more harm than good

2022 175 citations Kevin Bardosh, Alexandre de Figueiredo et al. BMJ Global Health profile →

Peers

Countries citing papers authored by Salmaan Keshavjee

Since Specialization

Citations

This map shows the geographic impact of Salmaan Keshavjee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salmaan Keshavjee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salmaan Keshavjee more than expected).

Fields of papers citing papers by Salmaan Keshavjee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salmaan Keshavjee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salmaan Keshavjee. The network helps show where Salmaan Keshavjee may publish in the future.

Co-authorship network of co-authors of Salmaan Keshavjee

This figure shows the co-authorship network connecting the top 25 collaborators of Salmaan Keshavjee. A scholar is included among the top collaborators of Salmaan Keshavjee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salmaan Keshavjee. Salmaan Keshavjee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Reparations and distributive justice in global health 2026 ·BMJ Global Health ·(unknown), Salmaan Keshavjee, Sonja Klinsky, (unknown), (unknown), Amit Thorat, Jason Hickel, (unknown), (unknown), William Darity, Hilary Beckles	0
2	Low Body Mass Index at Treatment Initiation and Rifampicin-Resistant Tuberculosis Treatment Outcomes: An Individual Participant Data Meta-Analysis 2022 ·Clinical Infectious Diseases ·Jonathon R. Campbell, Edward D. Chan, Dennis Falzon, Anete Trajman, Salmaan Keshavjee, Chi Chiu Leung, Ann C. Miller, (unknown), Denise S. Rodrigues, (unknown), Parvaneh Baghaei, Zarir Udwadia, Piret Viiklepp, Mayara Lisboa Bastos, Dick Menzies	10
3	The unintended consequences of COVID-19 vaccine policy: why mandates, passports and restrictions may cause more harm than good breakdown → 2022 ·BMJ Global Health ·Kevin Bardosh, Alexandre de Figueiredo, Rachel Gur‐Arie, Euzebiusz Jamrozik, James Doidge, Trudo Lemmens, Salmaan Keshavjee, Janice Graham, Stefan Baral	175
4	COVID-19 vaccine boosters for young adults: a risk benefit assessment and ethical analysis of mandate policies at universities 2022 ·Journal of Medical Ethics ·Kevin Bardosh, (unknown), Euzebiusz Jamrozik, Trudo Lemmens, Salmaan Keshavjee, Vinay Prasad, (unknown), Stefan Baral, Tracy Beth Høeg	26
5	A structured community engagement strategy to support uptake of TB active case-finding 2022 ·Public Health Action ·Jerome T. Galea, (unknown), (unknown), (unknown), (unknown), Judith Jiménez, Meredith B. Brooks, Courtney M. Yuen, Leonid Lecca, M. C. Becerra, Salmaan Keshavjee	7
6	Geographic accessibility to health facilities predicts uptake of community-based tuberculosis screening in an urban setting 2022 ·International Journal of Infectious Diseases ·Helen E. Jenkins, (unknown), (unknown), Meredith B. Brooks, (unknown), Judith Jiménez, Leonid Lecca, Jerome T. Galea, Mercedes C. Becerra, Salmaan Keshavjee, Courtney M. Yuen	9
7	Toward patient-centered tuberculosis preventive treatment: preferences for regimens and formulations in Lima, Peru 2021 ·BMC Public Health ·Courtney M. Yuen, (unknown), Jerome T. Galea, (unknown), Judith Jiménez, Leonid Lecca, Mercedes C. Becerra, Salmaan Keshavjee	12
8	Impact of latent tuberculosis infection on health and wellbeing: a systematic review and meta-analysis 2021 ·European Respiratory Review ·Yen Jun Wong, (unknown), Salmaan Keshavjee, Shaun Wen Huey Lee	12
9	COVID-19 reveals weak health systems by design: Why we must re-make global health in this historic moment 2020 ·Global Public Health ·(unknown), Seth M. Holmes, Tinashe Goronga, (unknown), (unknown), Raphael Frankfurter, Salmaan Keshavjee	96
10	Protocol for a case–control study of vitamin D status, adult multidrug-resistant tuberculosis disease and tuberculosis infection in Mumbai, India 2020 ·BMJ Open ·Nerges Mistry, Elena C. Hemler, Yatin Dholakia, Sabri Bromage, (unknown), (unknown), (unknown), (unknown), Daksha Shah, Salmaan Keshavjee, Wafaie Fawzi	4
11	The impact of the COVID-19 epidemic on tuberculosis control in China 2020 ·The Lancet Regional Health - Western Pacific ·Fei Huang, (unknown), Hui Chen, Ni Wang, Xin Du, Wei Chen, Tao Li, Shitong Huan, (unknown), Ming-Ting Chen, Salmaan Keshavjee, Yanlin Zhao, Daniel P. Chin, (unknown)	69
12	Blind Spot 2019 ·Salmaan Keshavjee	29
13	Map the gap: missing children with drug-resistant tuberculosis 2015 ·Public Health Action ·Courtney M. Yuen, Carly A. Rodriguez, Salmaan Keshavjee, M. C. Becerra	12
14	Low rates of recurrence after successful treatment of multidrug-resistant tuberculosis in Tomsk, Russia 2015 ·The International Journal of Tuberculosis and Lung Disease ·Irina Gelmanova, (unknown), M. C. Becerra, (unknown), (unknown), (unknown), (unknown), (unknown), Sonya Shin, Askar Yedilbayev, (unknown), Salmaan Keshavjee	15
15	Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis breakdown → 2015 ·Cold Spring Harbor Perspectives in Medicine ·Kwonjune J. Seung, Salmaan Keshavjee, Michael Rich	485
16	Isoniazid-resistant Tuberculosis in Children 2013 ·The Pediatric Infectious Disease Journal ·Courtney M. Yuen, Arielle W. Tolman, Ted Cohen, Jonathan B. Parr, Salmaan Keshavjee, Mercedes C. Becerra	25
17	Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes 2012 ·European Respiratory Journal ·Dennis Falzon, Neel R. Gandhi, Giovanni Battista Migliori, Giovanni Sotgiu, Helen Cox, Timothy H. Holtz, Maria-Graciela Hollm-Delgado, Salmaan Keshavjee, Kathryn DeRiemer, Rosella Centis, Lia D’Ambrosio, Christoph Lange, Melissa Bauer, Dick Menzies	259
18	Time for zero deaths from tuberculosis 2011 ·The Lancet ·Salmaan Keshavjee, Mark Harrington, Gregg Gonsalves, (unknown), Paul E. Farmer	5
19	Development of Extensively Drug-resistant Tuberculosis during Multidrug-resistant Tuberculosis Treatment 2010 ·American Journal of Respiratory and Critical Care Medicine ·Sonya Shin, Salmaan Keshavjee, Irina Gelmanova, Sidney Atwood, Molly F. Franke, Sergey P. Mishustin, А. К. Стрелис, (unknown), Alexander Pasechnikov, (unknown), (unknown), Ted Cohen	76
20	Early Outcomes of MDR-TB Treatment in a High HIV-Prevalence Setting in Southern Africa 2009 ·PLoS ONE ·Kwonjune J. Seung, (unknown), Salmaan Keshavjee, Jennifer Furin, Paul E. Farmer, Hind Satti	97

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact